AstraZeneca, Quell Make Collaboration Deal Worth Up To $2B
By Jade Martinez-Pogue ( June 9, 2023, 3:31 PM EDT) -- Biopharmaceutical giant AstraZeneca PLC on Friday announced that it has entered into an agreement with London-based Quell Therapeutics Ltd. to develop cell therapies for diabetes and inflammatory bowel disease in a deal that could be worth more than $2 billion....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.